165 related articles for article (PubMed ID: 17150157)
1. Role of poly(ADP-ribose) polymerase during vascular reconstruction.
Albadawi H; Crawford RS; Atkins MD; Watkins MT
Vascular; 2006; 14(6):362-5. PubMed ID: 17150157
[TBL] [Abstract][Full Text] [Related]
2. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.
Henning RJ; Bourgeois M; Harbison RD
Cardiovasc Toxicol; 2018 Dec; 18(6):493-506. PubMed ID: 29968072
[TBL] [Abstract][Full Text] [Related]
3. Caffeine metabolites are inhibitors of the nuclear enzyme poly(ADP-ribose)polymerase-1 at physiological concentrations.
Geraets L; Moonen HJ; Wouters EF; Bast A; Hageman GJ
Biochem Pharmacol; 2006 Sep; 72(7):902-10. PubMed ID: 16870158
[TBL] [Abstract][Full Text] [Related]
4. Poly(ADP-ribosyl)ation enhancement in brain cell nuclei is associated with diabetic neuropathy.
Kuchmerovska T; Shymanskyy I; Donchenko G; Kuchmerovskyy M; Pakirbaieva L; Klimenko A
J Diabetes Complications; 2004; 18(4):198-204. PubMed ID: 15207836
[TBL] [Abstract][Full Text] [Related]
5. Poly(ADP-Ribose) polymerase-1 in acute neuronal death and inflammation: a strategy for neuroprotection.
Skaper SD
Ann N Y Acad Sci; 2003 May; 993():217-28; discussion 287-8. PubMed ID: 12853316
[TBL] [Abstract][Full Text] [Related]
6. Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase.
Endres M; Wang ZQ; Namura S; Waeber C; Moskowitz MA
J Cereb Blood Flow Metab; 1997 Nov; 17(11):1143-51. PubMed ID: 9390645
[TBL] [Abstract][Full Text] [Related]
7. Role of poly(ADP-ribose) synthetase in inflammation and ischaemia-reperfusion.
Szabó C; Dawson VL
Trends Pharmacol Sci; 1998 Jul; 19(7):287-98. PubMed ID: 9703762
[TBL] [Abstract][Full Text] [Related]
8. Oxidant injury of cells. DNA strand-breaks activate polyadenosine diphosphate-ribose polymerase and lead to depletion of nicotinamide adenine dinucleotide.
Schraufstatter IU; Hinshaw DB; Hyslop PA; Spragg RG; Cochrane CG
J Clin Invest; 1986 Apr; 77(4):1312-20. PubMed ID: 2937805
[TBL] [Abstract][Full Text] [Related]
9. Lipid peroxidation, protein thiol oxidation and DNA damage in hydrogen peroxide-induced injury to endothelial cells: role of activation of poly(ADP-ribose)polymerase.
Kirkland JB
Biochim Biophys Acta; 1991 May; 1092(3):319-25. PubMed ID: 1904775
[TBL] [Abstract][Full Text] [Related]
10. BGP-15, a nicotinic amidoxime derivate protecting heart from ischemia reperfusion injury through modulation of poly(ADP-ribose) polymerase.
Szabados E; Literati-Nagy P; Farkas B; Sumegi B
Biochem Pharmacol; 2000 Apr; 59(8):937-45. PubMed ID: 10692558
[TBL] [Abstract][Full Text] [Related]
11. Effect of poly(ADP-ribose) polymerase inhibitors on the ischemia-reperfusion-induced oxidative cell damage and mitochondrial metabolism in Langendorff heart perfusion system.
Halmosi R; Berente Z; Osz E; Toth K; Literati-Nagy P; Sumegi B
Mol Pharmacol; 2001 Jun; 59(6):1497-505. PubMed ID: 11353811
[TBL] [Abstract][Full Text] [Related]
12. Beneficial effects of poly (ADP-ribose) polymerase inhibition against the reperfusion injury in heart transplantation.
Fiorillo C; Ponziani V; Giannini L; Cecchi C; Celli A; Nediani C; Perna AM; Liguori P; Nassi N; Formigli L; Tani A; Nassi P
Free Radic Res; 2003 Mar; 37(3):331-9. PubMed ID: 12688429
[TBL] [Abstract][Full Text] [Related]
13. Minocycline protects cardiac myocytes against simulated ischemia–reperfusion injury by inhibiting poly(ADP-ribose) polymerase-1.
Tao R; Kim SH; Honbo N; Karliner JS; Alano CC
J Cardiovasc Pharmacol; 2010 Dec; 56(6):659-68. PubMed ID: 20881608
[TBL] [Abstract][Full Text] [Related]
14. The therapeutic potential of poly(ADP-ribose) polymerase inhibitors.
Virág L; Szabó C
Pharmacol Rev; 2002 Sep; 54(3):375-429. PubMed ID: 12223530
[TBL] [Abstract][Full Text] [Related]
15. Poly (adp-ribose) polymerase inhibitors as potential therapeutic agents in stroke and neurotrauma.
Komjáti K; Besson VC; Szabó C
Curr Drug Targets CNS Neurol Disord; 2005 Apr; 4(2):179-94. PubMed ID: 15857303
[TBL] [Abstract][Full Text] [Related]
16. A novel and potent poly(ADP-ribose) polymerase-1 inhibitor, FR247304 (5-chloro-2-[3-(4-phenyl-3,6-dihydro-1(2H)-pyridinyl)propyl]-4(3H)-quinazolinone), attenuates neuronal damage in in vitro and in vivo models of cerebral ischemia.
Iwashita A; Tojo N; Matsuura S; Yamazaki S; Kamijo K; Ishida J; Yamamoto H; Hattori K; Matsuoka N; Mutoh S
J Pharmacol Exp Ther; 2004 Aug; 310(2):425-36. PubMed ID: 15075382
[TBL] [Abstract][Full Text] [Related]
17. Poly(ADP-ribose) polymerase-1 activation during DNA damage and repair.
Dantzer F; Amé JC; Schreiber V; Nakamura J; Ménissier-de Murcia J; de Murcia G
Methods Enzymol; 2006; 409():493-510. PubMed ID: 16793420
[TBL] [Abstract][Full Text] [Related]
18. Myocardial postischemic injury is reduced by polyADPripose polymerase-1 gene disruption.
Pieper AA; Walles T; Wei G; Clements EE; Verma A; Snyder SH; Zweier JL
Mol Med; 2000 Apr; 6(4):271-82. PubMed ID: 10949908
[TBL] [Abstract][Full Text] [Related]
19. Poly(ADP-ribose) polymerase-mediated cell injury in acute renal failure.
Devalaraja-Narashimha K; Singaravelu K; Padanilam BJ
Pharmacol Res; 2005 Jul; 52(1):44-59. PubMed ID: 15911333
[TBL] [Abstract][Full Text] [Related]
20. NAD+ as a metabolic link between DNA damage and cell death.
Ying W; Alano CC; Garnier P; Swanson RA
J Neurosci Res; 2005 Jan 1-15; 79(1-2):216-23. PubMed ID: 15562437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
